Podcasts about patient access

In this episode of ACRO's GCP, Tinaya Gray (Executive Director, Site Engagement & PACE at ICON plc), Jan Hewett (SVP, FDA Regulatory Advisor at Advarra), and Jackie Kent (Independent Advisor) unpack the work of ACRO's dive team on representative, generalizable clinical trial data at the 2025 Innovation Network Gathering. Together, they explore why clinical trial populations still fail to reflect real-world patients, and what's been holding the industry back from meaningful progress.The conversation goes beyond identifying the problem. The group shares how a diverse set of stakeholders were able to align around practical, implementable solutions. They also discuss how industry can pilot new approaches, engage broader stakeholders, and turn promising ideas into standard practice. This episode offers a candid and solutions-oriented look at how to generate clinical data that truly supports better decision-making for all patients.

2026 is the year of a major wave of pharmaceutical patent expirations, with numerous blockbuster drugs – spanning diabetes, immunology, cardiovascular, oncology, and other therapeutic areas – on the verge of losing market exclusivity. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Rebecca Guntern, chief commercial officer at Sandoz, for a conversation on the ‘golden decade' for generics and biosimilars as so many blockbuster drugs come off patent. Guntern discusses why the current wave of blockbuster biologics losing exclusivity is so significant for patient access and healthcare budgets, and the conversation also touches upon policy and regulatory changes still needed in order to unlock the full potential of biosimilars, as well as what should be expected from the next generation of biosimilars. You can listen to episode 263 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

In this special podcast episode, I. Paul Singh, MD, speaks with Deborah Ristvedt, DO, and Kevin Talbot, MD, regarding the use of iDose TR (Glaukos), a procedural pharmaceutical, as an interventional glaucoma approach. They outline who the optimal patients are for this procedure, how to educate patients about drug delivery technology, and share pearls on reimbursement.

A rapid-fire segment highlighting positive developments in digital health. Janae and Megan share insights on recent innovations, successful implementations, and emerging trends that are driving progress in healthcare technology. Learn about cutting-edge solutions improving patient outcomes Discover how technology is enhancing healthcare accessibility Gain insight into successful digital health implementations Stay informed about positive industry trends shaping the future of care Janae Sharp, Founder, The Sharp Index Megan Antonelli, Chief Executive Officer, HealthIMPACT Live

What does it actually cost when a doctor writes a verbal order over the phone instead of seeing the patient? Scott Middleton has the receipts — and the answer is going to make you rethink everything about how American healthcare spends its money. In this episode of The Disrupted Podcast, Scott announces a landmark three-way merger bringing Your Health together with Transitional Care Professionals of America (TCPA) out of Georgia and Providence Care, a hospice organization in South Carolina. The combined organization will serve approximately 55,000 active patients — not patients on a list, but people being seen regularly — and Scott lays out exactly how he's going to run it. What you'll hear in this episode: Why Scott's family owning 80% of the merged company changes everything about how decisions get made — and who they get made for The difference between fee-for-service and value-based care, and why the ACO model means every unnecessary hospitalization literally comes out of Your Health's pocket How Your Health's risk-adjustment-based visit model (16 visits per year per risk point) was independently validated by a new government study — and why it works The three things Scott is asking every new employee to do in the first weeks: align with a nurse practitioner, track every minute of care management, and recruit like their livelihood depends on it — because it does Why Scott's new management philosophy is six words: "Keep them out of the hospital and see your damn patients" This isn't a corporate announcement. It's a playbook for how healthcare can actually work when operators run the company, providers see their patients, and every minute of care gets counted. www.YourHealth.Org

What does it take to make sure innovation, policy, and public health actually work for older adults? Too often, patients and caregivers face a hard path from diagnosis to treatment, shaped by Medicare complexity, out-of-pocket costs, communication gaps, and administrative barriers that get in the way of care.In this episode of Patient Advocacy Voices, host Eric Racine is joined by co-host Katie Oppenheim, Head of US Government Relations at Sanofi, for a conversation with Sue Peschin, President and CEO of the Alliance for Aging Research. Together, they discuss how aging research, Medicare policy, vaccine education, and patient advocacy come together to shape access and outcomes for older adults.Sue shares how the Alliance for Aging Research is working to change the narrative on healthy aging, advance evidence-based policy, and help patients better navigate the system. Drawing both on her leadership experience and her personal perspective as a caregiver, she offers practical insight into the barriers older adults face and what it takes to reduce them.In this episode, you'll hear about:How Medicare benefit design, affordability, and utilization management can affect real patient accessWhy aging research matters for chronic disease, infectious disease, and healthier lives as people ageHow advocacy organizations help translate complex policy changes into useful guidance for patients and familiesWhy vaccine education and trusted communication still matter, especially for older adultsWhat mission-driven leadership looks like during times of policy and public health changeThis episode offers practical lessons for advocacy leaders, policymakers, and anyone working to make the healthcare system easier to navigate for older adults and caregivers.

Automation is changing patient access, but prior authorization still requires more than bots, portals, and percentage-based promises. In this episode, Lindsey Nelson, Product Marketing Director at Infinx, explores why agentic workflows, human expertise, clinical judgment, and operational visibility all matter when organizations are trying to reduce delays, avoid denials, and keep work moving.

We love to hear from our listeners. Send us a message.In episode 129 of Cell & Gene: The Podcast, Host Erin Harris reconnects with Zachary Roberts, M.D., Ph.D., EVP of Research & Development and Chief Medical Officer at Allogene Therapeutics, to explore how allogeneic CAR-T is evolving from a scalability promise into an earlier-line, potentially curative intervention. Their conversation centers on the ALPHA3 trial, where MRD-guided treatment is redefining when and how CAR-T can be deployed, alongside broader implications for diagnostics, patient access, and the shift toward off-the-shelf therapies in community settings.Subscribe to the podcast!Apple  |  Spotify |  YouTubeVisit my website: Cell & GeneConnect with me on LinkedIn

Smoother Schedules Start With Smarter Prior Authorization Lora Pada, VP of Customer Success at Infinx, host a practical conversation with Danelle Newman, Director of Patient Access at OSS Health, on how orthopedic practices can take a smarter approach to prior authorization workflows. The discussion will focus on the real operational grind patient access teams face every day, including payer complexity, manual follow-up, documentation gaps, scheduling pressure, and the challenge of keeping patients moving without overwhelming staff. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Same-day cancellations, delayed procedures, and scheduling disruption can create major strain for orthopedic practices. In this Office Hours Takeover, Lora Pada, VP of Customer Success at Infinx, speaks with Danelle Newman, Director of Patient Access at OSS Health, about the role prior authorization workflows play in keeping schedules moving, reducing preventable delays, and giving patient access teams more breathing room.Brought to you by www.infinx.com

Patty Hayward, General Manager of healthcare and life sciences at Talkdesk, describes how a hybrid model of humans and AI is reshaping healthcare contact centers. Patient access and revenue cycle management are the primary, interconnected challenges for these centers, and modern large-language AI is being used to handle complex scheduling logic. Data analytics helps identify patterns in patient inquiries, predict demand peaks, and move care from reactive to proactive. The expectation is that AI agents will guide patients, becoming a normal and accepted part of healthcare. Patty explains, "I think that the challenge has always been in healthcare that it's difficult to automate things in comparison to other industries. If you call retail, it's very hard to get a human. You're constantly dealing with bots or being deflected to digital front doors versus in healthcare, as much as organizations have tried to push people to the digital apps and MyCharts and different things like that, it's been difficult. And there are good reasons, and there are bad reasons for that."   "When you think about scheduling, scheduling really drives your revenue cycle because if people don't come to your organization, you can't bill them for things, you can't bill their insurance. And so your organization has problems with the revenue cycles. That's why I say they're inextricably linked, and it's very important to solve the access problem in order to solve the revenue cycle problem."  "So, making sure that you match that patient with the right provider, making sure that you have the right requirements around insurance authorization and things like that. And then, of course, letting the patient understand what their burden will be as far as the charges go for that appointment is all part of the dance, so to speak. And that really requires a large language model that can consume and understand that information. You're right, the decision trees weren't going to work as far as an AI piece goes." #Talkdesk #AgenticAI #AIAgents #ArtificialIntelligence #AI  #Automation #CustomerServiceAutomation #ValuebasedCare #VBC #PatientExperience #MemberExperience #CustomerExperience #Providers #Payers #HealthcareAI #PatientExperience #HealthTech #ContactCenters #AIInHealthcare #DigitalTransformation #HealthcareInnovation #PatientAccess #RevenueOptimization #HealthcareLeadership talkdesk.com Download the transcript here

Patty Hayward, General Manager of healthcare and life sciences at Talkdesk, describes how a hybrid model of humans and AI is reshaping healthcare contact centers. Patient access and revenue cycle management are the primary, interconnected challenges for these centers, and modern large-language AI is being used to handle complex scheduling logic. Data analytics helps identify patterns in patient inquiries, predict demand peaks, and move care from reactive to proactive. The expectation is that AI agents will guide patients, becoming a normal and accepted part of healthcare. Patty explains, "I think that the challenge has always been in healthcare that it's difficult to automate things in comparison to other industries. If you call retail, it's very hard to get a human. You're constantly dealing with bots or being deflected to digital front doors versus in healthcare, as much as organizations have tried to push people to the digital apps and MyCharts and different things like that, it's been difficult. And there are good reasons, and there are bad reasons for that."   "When you think about scheduling, scheduling really drives your revenue cycle because if people don't come to your organization, you can't bill them for things, you can't bill their insurance. And so your organization has problems with the revenue cycles. That's why I say they're inextricably linked, and it's very important to solve the access problem in order to solve the revenue cycle problem."  "So, making sure that you match that patient with the right provider, making sure that you have the right requirements around insurance authorization and things like that. And then, of course, letting the patient understand what their burden will be as far as the charges go for that appointment is all part of the dance, so to speak. And that really requires a large language model that can consume and understand that information. You're right, the decision trees weren't going to work as far as an AI piece goes." #Talkdesk #AgenticAI #AIAgents #ArtificialIntelligence #AI  #Automation #CustomerServiceAutomation #ValuebasedCare #VBC #PatientExperience #MemberExperience #CustomerExperience #Providers #Payers #HealthcareAI #PatientExperience #HealthTech #ContactCenters #AIInHealthcare #DigitalTransformation #HealthcareInnovation #PatientAccess #RevenueOptimization #HealthcareLeadership talkdesk.com  Listen to the podcast here

Pharma and tech companies are working more closely together than ever. As proven by the news of Merck and NVidia's new partnership, for example. But while the idea of using AI for drug discovery has been around for a while now, patient access has an awfully long way to catch up to the promise of these new therapies. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dean Erhardt, founder of D2 Solutions, an end-to-end strategic partner delivering industry-leading consulting and purpose-built technologies to pharma manufacturers, hospitals, pharmacies, payers & PBMs. The conversation focuses on the disconnect between distributions, reimbursements, and patient services, particularly when it comes to speciality medicines, as well as patient access today versus the state of patient access tomorrow, and the benefit or otherwise of price protection guarantees with PBMs, when it comes to new therapies. You can listen to episode 256 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

In this episode, Charlie Lougheed, CEO and co-founder, Axuall, and James Whitfill, MD, Senior Vice President of Strategic Partnerships and Chief Transformation Officer, HonorHealth, discuss how accurate provider data and AI are reshaping patient access and care delivery. They explore data governance, the risks of poor data quality, and how better infrastructure can improve matching, efficiency, and patient outcomes.This episode is sponsored by Axuall.

Access to care in an ambulatory setting continues to challenge health systems as patient expectations grow, pushing organizations to rethink how patients connect with care. Our host Michelle Lewis joins Tyler Bauer, Senior Vice President of System Ambulatory Operations at University of Chicago Medicine to explore how their team is transforming access through more connected and intuitive processes.  Guest: Tyler Bauer, MA, MBA, LCPC Senior Vice President, System Ambulatory Operations UChicago Medicine   Host: Michelle Lewis Senior Director Programs, Performance Improvement Programs Vizient    Show Notes:  [00:45] Areas of improvement in ambulatory access  [02:16] Biggest pain points for patients: connectedness, personalization, and navigation  [03:51] Creating an omnichannel experience  [04:43] AI tools being brought in to help with access strategy  [06:18] Using ambient listening and other AI tools to make a difference for patients and staff  [08:26] Organizational buy-in and compliance with AI application strategy  [10:31] Advice to other healthcare organizations    Links | Resources: Contacting Knowledge on the Go: picollaboratives@vizientinc.com    Subscribe Today! Apple Podcasts Spotify YouTube Android RSS Feed  

In this episode of Home Health Revealed, Hannah Vale sits down with Alex Hartzman, Vice President of Research & Analytics at the National Alliance for Care at Home and Head of Operations at the Research Institute for Home Care, to discuss the policy, payment, and workforce trends shaping the future of home health. They explore the ongoing pressure from Medicare reimbursement changes, the impact of value-based purchasing and quality metrics, and the growing workforce challenges affecting agencies across the country. The conversation also dives into the increasing demand for home-based care, access-to-care concerns, and why the story of home health is not always reaching policymakers the way it should. If you're a home health leader trying to prepare for the years ahead, this episode offers an inside look at the data, policy conversations, and industry realities that will define the future of care at home. Listeners interested in getting involved in advocacy efforts can learn more through the National Alliance for Care at Home Advocacy Action Center and find details about Alliance membership opportunities on their website. The Alliance DC Advocacy Fly-In will take place September 13–16, and Alliance members will receive registration information directly. Chapters (00:00:03) - Home Health Revealed(00:00:25) - Alex Hartzman on Policy Influence in Home Care(00:01:27) - Top 3 issues facing home health agencies(00:05:30) - What Can an Average Home Health Agency Do to Improve Their Quality Score(00:09:37) - Risk of rehospitalization(00:10:35) - Home Health Agency Executives on Staff turnover(00:14:15) - The value of home health(00:19:49) - Home Health and Hospice: A Conversation

In this episode, Megan Eubanks, MBA, Senior Director of Business Operations for Perioperative and Procedural Services at The University of Kansas Health System, discusses how her team is using AI and advanced analytics to improve operating room utilization, increase surgical volume, and expand patient access to care. She also shares lessons on building resilient perioperative operations through transparency, governance, and data driven decision making.

In this episode, Steve Smith, Assistant Vice President of Enterprise Contact Center and Access at Inova Health System, shares how the organization is leveraging cloud based technology, digital assistants, and AI driven tools to streamline scheduling, improve self service, and enhance both patient and team member experiences.

Send a textClinical Artificial Intelligence in 2026. Accuracy, Education, and GuardrailsArtificial intelligence is evolving fast in medicine. But how accurate is it. And are we building it safely?In this episode of DigiPath Digest, I review five new studies shaping digital pathology, radiology, burn diagnostics, and agent-based large language model systems. We discuss accuracy gains, hallucination filtering, education challenges, and why safeguards are essential before clinical deployment.Clear. Practical. Evidence-based.⏱ Topics & Timestamps[00:02] Introduction Weekly journal club on digital pathology and artificial intelligence.[05:13] Hallucination Filtering in Radiology Using Discrete Semantic Entropy to detect hallucination-prone responses in Vision Language Models. Accuracy improved from 51.7 percent to 76.3 percent after filtering high-entropy answers.[15:04] Artificial Intelligence in Pathology Training Supervised use during residency. Balancing artificial intelligence adoption with preservation of morphological analysis and critical thinking.[20:12] Colorectal Cancer Lymph Node Detection Two-stage classification and segmentation model in Whole Slide Imaging. Recall 1.0. Specificity 0.935. Dice coefficient 0.818. Artificial intelligence as a second opinion.[25:04] Burn Depth Prediction with Artificial Intelligence Tissue Doppler Elastography and Harmonic B-mode ultrasound combined with artificial intelligence. 90 to 95 percent accuracy in human subjects.[31:20] Agent-Based Large Language Model Systems OpenManus and Manus evaluated in clinical simulations. Up to 60.3 percent accuracy. High computational cost. 89.9 percent of hallucinations filtered by safeguards.[40:08] Patient Access to Pathology Images Why viewing pathology slides can empower patients and improve communication.Resourceshttps://pubmed.ncbi.nlm.nih.gov/41720937/https://pubmed.ncbi.nlm.nih.gov/41720644/https://pubmed.ncbi.nlm.nih.gov/41716065/https://pubmed.ncbi.nlm.nih.gov/41709317/https://pubmed.ncbi.nlm.nih.gov/41708802/Support the showGet the "Digital Pathology 101" FREE E-book and join us!

Part II: How Telehealth is Redefining Clinical Practice and Patient Access Join us for part two of a two-part interview with Dr. Brandon Welch, founder and CEO of doxy.me; a platform that has facilitated over 8 billion minutes of care across 1 million providers in 176 countries. With the administration signing the Consolidated Appropriations Act on February 3, 2026, extending Medicare telehealth flexibilities through December 2027, and patient demand driving unprecedented adoption, virtual care has moved from emergency response to fundamental transformation of clinical practice. Brandon examines how the proliferation of telehealth is reshaping medicine itself: clinical workflows, patient-provider relationships, access equity, and sustainable practice models. Drawing from his book Telehealth Success, he delivers actionable strategies for healthcare leaders navigating the five pillars determining telehealth ROI: patient engagement, clinician efficiency, technology scalability, financial viability, and regulatory compliance in an era where patients expect care everywhere. • Five-pillar framework for achieving sustainable telehealth success across organizations • Financial sustainability models leveraging the two-year Medicare telehealth extension through 2027 • Clinical practice transformation reshaping how medicine is delivered and experienced • Provider success strategies addressing burnout, workflow integration, and practice transformation • Access and equity insights from 176-country, 1 million+ provider implementation Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Part I: How Telehealth is Redefining Clinical Practice and Patient Access Join us for part I of a two-part interview with Dr. Brandon Welch, founder and CEO of doxy.me; a platform that has facilitated over 8 billion minutes of care across 1 million providers in 176 countries. With the administration signing the Consolidated Appropriations Act on February 3, 2026, extending Medicare telehealth flexibilities through December 2027, and patient demand driving unprecedented adoption, virtual care has moved from emergency response to fundamental transformation of clinical practice. Brandon examines how the proliferation of telehealth is reshaping medicine itself: clinical workflows, patient-provider relationships, access equity, and sustainable practice models. Drawing from his book Telehealth Success, he delivers actionable strategies for healthcare leaders navigating the five pillars determining telehealth ROI: patient engagement, clinician efficiency, technology scalability, financial viability, and regulatory compliance in an era where patients expect care everywhere. • Five-pillar framework for achieving sustainable telehealth success across organizations • Financial sustainability models leveraging the two-year Medicare telehealth extension through 2027 • Clinical practice transformation reshaping how medicine is delivered and experienced • Provider success strategies addressing burnout, workflow integration, and practice transformation • Access and equity insights from 176-country, 1 million+ provider implementation Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Revenue Cycle Optimized, Jennifer Glockzin, Senior Director of Patient Access at Infinx, walks through the real-world prior authorization process from intake to determination and appeals. Her breakdown highlights how disciplined workflows, supported by AI agent automation and coordinated human in-the-loop, protect revenue and reduce preventable denials.

Biopharmaceutical innovation is advancing at an unprecedented pace, yet many patients still face barriers to accessing new medicines. In this episode of Health Matters, John O’Brien, president and CEO of the National Pharmaceutical Council, speaks with Kristin Cahill about why policy, pricing and benefit design are increasingly shaping whether innovation reaches patients. O’Brien shares insights from his career spanning pharmaceutical companies, health plans and government, including his time as a senior drug pricing advisor during the first Trump administration. He explains why prescription drugs remain a focal point in cost debates, what policymakers often misunderstand about value, and how middlemen and misaligned incentives affect what patients pay at the pharmacy counter. The conversation also examines emerging approaches such as direct-to-patient models, most-favored-nation pricing and the early effects of the Inflation Reduction Act, highlighting potential benefits as well as risks to access and future innovation. For healthcare professionals, payers and marketers seeking clarity in a complex policy environment, this episode offers a grounded perspective on how to ensure medical breakthroughs translate into meaningful patient benefit. Listen to the full interview.See omnystudio.com/listener for privacy information.

When a claim fails because of a missing field or outdated insurance detail, it is easy to blame the billing process, but it is incomplete or inconsistent information captured at registration that is often the root cause. This seemingly innocuous oversight may be the reason why AI adoption in revenue cycle management (RCM) has been slow. In this conversation, Clarissa Riggins, Chief Product Officer at Experian Health, and Amy Trogdon, Vice President of Patient Access at Integris Health, break down why AI adoption in RCM depends on accurate front-end data and workflow fit. They share what they learned rolling out Experian's Patient Access Curator inside Epic and how real-time coverage validation is reshaping staff trust and efficiency. You will hear candid insights about workforce strain, error-prone processes, and why many AI projects stall before they start.

What if patient access isn't just an operational problem—but a shared organizational belief system?In this episode of All Access Pass, host Chris Profeta, Senior Director of Research and Analytics at the Patient Access Collaborative, sits down with Austin Loomis, AVP of Ambulatory Access and Analytics, Mandy Newman, MAAL, Vice President of Ambulatory Operations, and Catherin Mims, MD, Vice President and Associate Chief Physician Executive for the Ambulatory Practice at OU Health. Together, they unpack a new evolution of the Patient Access Framework: a group-based assessment that captures how access is perceived across an entire organization.With more than 20 leaders—from finance and HR to physician chairs and executive leadership—participating in the assessment, OU Health gained a rare, enterprise-wide view of access. The conversation explores what happens when those perspectives align, where they diverge, and why those gaps often represent the greatest opportunities for system improvement. Along the way, the group reflects on why access blind spots persist, how shared language changes strategy, and what it means to truly measure access as an enterprise responsibility.Tune in to hear how group assessments can surface hidden friction, strengthen cross-departmental alignment, and turn access from a siloed function into a shared organizational priority—covering the evolution of the Patient Access Framework, the rationale behind group scoring, leadership alignment, organizational blind spots, and practical insights for system-level access improvement.Woodcock, E., Profeta, C. A framework for patient access management: consensus from a Delphi panel of US health system leaders. BMC Health Serv Res 25, 524 (2025). https://doi.org/10.1186/s12913-025-12561-8https://link.springer.com/article/10.1186/s12913-025-12561-8

Ambulatory leaders may believe care access problems are solved because their utilization metrics are high. However, these numbers may be hiding demand mismatches at the patient, provider, and clinic level. Discover how examining patient mix, no-shows, and late cancellations can help boost access to care and stop revenue leakage. 

In this episode, Melissa Majerol, Model Lead of the Cell and Gene Therapy Access Model at the Center for Medicare and Medicaid Innovation (CMMI) at CMS, breaks down how the CMMI Access Model program aims to simplify and accelerate patient access to innovative cell and gene therapies, starting with recently approved therapies in Sickle Cell disease. Listen in as we dive into the specifics of this new access model and its current status. Music: ‘Bright New Morning’ by Steven O’Brien – released under CC-BY 4.0. https://www.steven-obrien.net/Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

In this episode, Michael sits down with Reid Zeising, CEO of GAIN, the largest revenue cycle management organization specializing in litigated and complex healthcare claims. The conversation pulls back the curtain on how healthcare providers struggle to get paid for services already delivered, and how technology and AI are being used to push back against decades of insurance-driven denial strategies. Reid explains how the insurance industry fundamentally changed in 1994, when Allstate introduced Colossus, a system designed to standardize and often suppress claim payouts in favor of shareholder value. That shift, he argues, still shapes today's reimbursement environment, leaving providers underpaid and patients caught in the middle. Drawing on Michael's background in primary care administration, the discussion highlights a stark reality: many healthcare organizations collect only a fraction of what they bill, even when care is medically necessary and properly delivered. Reid compares this to asking professionals to do full work for partial pay and explains why this model is unsustainable, especially for providers serving uninsured and underinsured populations. The conversation then turns to how GAIN is using AI, predictive analytics, and technology-enabled workflows to reverse that imbalance. By focusing on litigated and complex claims, GAIN helps providers recover fair compensation, improve cash flow, and continue offering care to communities that need it most. Reid also shares why his company intentionally shifted away from higher-margin claim financing toward a service-driven model built around access, transparency, and long-term system impact. Michael and Reid also explore the broader healthcare landscape, including the financial strain on providers, the coming “silver tsunami” of aging patients, and the consequences of tort reform on patient access to care. Reid challenges common insurance-industry narratives around “frivolous lawsuits,” explaining how language and lobbying efforts have been used to restrict legitimate claims and reduce accountability. The episode closes with Reid's advocacy work through Americans for Patient Access and Americans for Responsible Consumer Funding, organizations focused on protecting access to healthcare and helping individuals navigate overwhelming medical and financial challenges. This is a candid, systems-level conversation about healthcare economics, AI-driven disruption, and what it will take to ensure providers get paid and patients get care. https://gainservicing.com/ https://www.linkedin.com/in/reidzeising/  

In this episode, Peyton Fry, Founder of Glass Raven, explains how leading hospitals are using data science & staffing analytics to improve patient access, reduce leakage & boost revenue capture. 

Ro Wickramasinghe, Vice President and Head of Global Business at Pi Health, identifies fundamental problems plaguing clinical trials, including operational inefficiencies and limited access to trials. Pi Health is addressing these challenges by developing an integrated software platform for clinical trial sponsors, sites, and patients and partnering with community-based cancer treatment centers worldwide.  The company has built a hospital in India to serve as a living laboratory to test and refine its model to democratize access and increase the ethnic diversity of trial participants.  Ro explains, "I think the challenge has always been, from a pharma-biotech perspective, is to find patients, but, from the other perspective, its patients participating in trials and being able to find clinical trials. So a lot of stats get bandied around, but despite many eligible patients, the percentage of eligible patients who actually end up in a clinical trial is really small. It's like 5% to 8%, so not a huge amount. I think that's kind of one problem."  "So we have it in chicken and egg scenario where we as a company develop clinical trial software, but when ultimately the vision for us is for that to really become the standard of care and really make trials more efficient for the clinicians that treat the patients and run the trials for these pharma companies and biotech companies that develop the drugs and sponsor the study."  "But having said that, I think to run lots of studies, what we decided to do was to build our own cancer hospital in India. And the beauty of that is that it is fully vertically integrated at the point of care. So the data gets captured on those patients in FICS, which is the software we've developed and then we can run trials. We have run trials for pharma and biotech at that site using our software. So it was, I guess, one of the quicker ways to test the software in a real-world environment and also getting lots of data on FICS and how it can benefit patients from the point of care to being on trials."  #PiHealth #ClinicalTrials #HealthTech #CancerResearch #Innovation #DigitalHealth #PharmaTech #PatientAccess #MedTech #Healthcare #ClinicalResearch #GlobalHealth #HealthcareInnovation #India Pihealth.ai Download the transcript here

Ro Wickramasinghe, Vice President and Head of Global Business at Pi Health, identifies fundamental problems plaguing clinical trials, including operational inefficiencies and limited access to trials. Pi Health is addressing these challenges by developing an integrated software platform for clinical trial sponsors, sites, and patients and partnering with community-based cancer treatment centers worldwide.  The company has built a hospital in India to serve as a living laboratory to test and refine its model to democratize access and increase the ethnic diversity of trial participants.  Ro explains, "I think the challenge has always been, from a pharma-biotech perspective, is to find patients, but, from the other perspective, its patients participating in trials and being able to find clinical trials. So a lot of stats get bandied around, but despite many eligible patients, the percentage of eligible patients who actually end up in a clinical trial is really small. It's like 5% to 8%, so not a huge amount. I think that's kind of one problem."  "So we have it in chicken and egg scenario where we as a company develop clinical trial software, but when ultimately the vision for us is for that to really become the standard of care and really make trials more efficient for the clinicians that treat the patients and run the trials for these pharma companies and biotech companies that develop the drugs and sponsor the study."  "But having said that, I think to run lots of studies, what we decided to do was to build our own cancer hospital in India. And the beauty of that is that it is fully vertically integrated at the point of care. So the data gets captured on those patients in FICS, which is the software we've developed and then we can run trials. We have run trials for pharma and biotech at that site using our software. So it was, I guess, one of the quicker ways to test the software in a real-world environment and also getting lots of data on FICS and how it can benefit patients from the point of care to being on trials."  #PiHealth #ClinicalTrials #HealthTech #CancerResearch #Innovation #DigitalHealth #PharmaTech #PatientAccess #MedTech #Healthcare #ClinicalResearch #GlobalHealth #HealthcareInnovation #India Pihealth.ai Listen to the podcast here

Dr. Lisa Mathew interviews Dr. Steven Klein of Wilmington Gastroenterology about how UnitedHealthcare's recent 15% reimbursement reduction for anesthesia services provided by certified registered nurse anesthetists (CRNAs) could affect the way independent gastroenterology practices structure anesthesia services and maintain patient access to procedures such as colonoscopy. Dr. Klein explains how independent GI practices rely on CRNAs to provide anesthesia and how those services are structured within his practice, offering a practical view of how insurer policy decisions can reshape care delivery in outpatient endoscopy settings. Join Dr. Mathew and Dr. Klein as they examine how this policy compounds existing pressures such as prior authorization requirements and site-of-service restrictions, the downstream effects on colorectal cancer screening and other procedures, and what insurers and policymakers need to understand about the real-world impact of these decisions on patient access. Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, episode 88, presented by TissueCypher from Castle Biosciences

South Carolina Medical Association (SCMA) immediate past president Mayes DuBose, MD and Vice President of Advocacy and Policy Counsel Holly Pisarik discuss efforts that the association has led in fighting bills that would allow unsupervised practice rights to NPs and PAs after just 2,000 hours of clinical hour experience - and let PAs switch specialties after just 1,000 hours.https://www.scmedical.org/Get the books: Patients at Risk https://www.amazon.com/dp/B08M9YJQR3/Imposter Doctors: https://www.amazon.com/dp/1627344438/PhysiciansForPatientProtection.org

Patient access is often measured by speed—but its true value runs much deeper.In this episode of The All-Access Pass, Elizabeth Woodcock, DrPH, MBA, is joined by Brett Butler, Vice President of Access Services at Baylor Scott & White Health, for a candid conversation about what it really takes to elevate access from a transactional function to a system-level strategy.Together, they explore how governance, relationships, and intentional design can unlock capacity, improve clinician experience, and create more equitable, patient-centered care—even amid financial pressure and constrained supply. Brett shares how Baylor Scott & White is scaling access across a complex, multi-market enterprise, why fragmentation is access's greatest enemy, and how technology can illuminate opportunity rather than promise false fixes.This episode challenges access leaders to ask a different question: not how fast can we schedule, but how might we redesign care to truly meet demand—for patients, clinicians, and the system alike.

Peyton Fry, Founder and owner of Glass Raven, discusses the complexities of patient access to healthcare and how healthcare systems often fall into the trap of measuring efficiency in ways that are financially beneficial for providers but are detrimental to patient care. Glass Raven helps organizations define key metrics of good patient access and the implementation of technology and AI to address the defined problems. This data-driven approach focuses on the populations most likely to benefit from improved patient access to care and informs a tailored, context-aware strategy for each healthcare system. Peyton explains, "Glass Raven focuses on providing services in patient access spaces and operations for healthcare systems. We typically work with medium to large healthcare systems and help them really get a feel and eyes on their own operations and what patient access means to them. Oftentimes, that starts with just defining what patient access is for a given space and then looking into call centers, referrals, and capacity to make sure that patients who want to be scheduled can be scheduled and that healthcare systems can control costs and gather the revenue from that."   "I think patient access has been around for a long time. I think it probably falls under a lot of different umbrellas, which is part of the problem. If I started my career, I found that there just weren't many experts who focused on patient access as a discipline. I think that's because your patient access strategies will change depending on your payer mix. It'll change depending on your size and your capabilities as a system. So I think it's really hard to find the blueprint that someone else has used and move it from system to system. It's almost like you have to reinvent the wheel." #GlassRaven #HealthcareAccess #PatientExperience #HealthTech #AIinHealthcare #HealthcareOperations #DataAnalytics #HealthcareInnovation #PatientCare #HealthSystems #DigitalHealth GlassRaven.Health Listen to the podcast here

Peyton Fry, Founder and owner of Glass Raven, discusses the complexities of patient access to healthcare and how healthcare systems often fall into the trap of measuring efficiency in ways that are financially beneficial for providers but are detrimental to patient care. Glass Raven helps organizations define key metrics of good patient access and the implementation of technology and AI to address the defined problems. This data-driven approach focuses on the populations most likely to benefit from improved patient access to care and informs a tailored, context-aware strategy for each healthcare system. Peyton explains, "Glass Raven focuses on providing services in patient access spaces and operations for healthcare systems. We typically work with medium to large healthcare systems and help them really get a feel and eyes on their own operations and what patient access means to them. Oftentimes, that starts with just defining what patient access is for a given space and then looking into call centers, referrals, and capacity to make sure that patients who want to be scheduled can be scheduled and that healthcare systems can control costs and gather the revenue from that."   "I think patient access has been around for a long time. I think it probably falls under a lot of different umbrellas, which is part of the problem. If I started my career, I found that there just weren't many experts who focused on patient access as a discipline. I think that's because your patient access strategies will change depending on your payer mix. It'll change depending on your size and your capabilities as a system. So I think it's really hard to find the blueprint that someone else has used and move it from system to system. It's almost like you have to reinvent the wheel." #GlassRaven #HealthcareAccess #PatientExperience #HealthTech #AIinHealthcare #HealthcareOperations #DataAnalytics #HealthcareInnovation #PatientCare #HealthSystems #DigitalHealth GlassRaven.Health Download the transcript here

Send us a textReferrals are meant to connect patients to the care they need, but in reality, they often become a source of delays, dropped handoffs, and administrative chaos. Between intake complexity, missing information, and outdated processes, too many patients get stuck between diagnosis and treatment. Trey Holterman, Co-Founder and CEO of Tennr joins CareTalk host John Driscoll to discuss why referrals break down so often, what makes intake workflows so hard to fix, and how health systems can improve throughput and access without ripping out the systems they already rely on. 

This year's biggest patient access wins didn't come from trend decks or theoretical frameworks — they came from listening. In this episode, we share the patterns Infinx heard repeatedly across calls with our clients, and what those signals revealed about what actually moved the needle in patient access.

2025 was the year AI agents moved from buzzword to real operational partners across the revenue cycle. In this episode, we look back at how eligibility, prior auth, document capture, and AR optimization all shifted toward faster, more predictable, and more proactive workflows.

AI may automate the “what” of scheduling, but the “why” still belongs to humans. In this episode of All Access Pass, host Elizabeth Woodcock sits down with Aramis Cherrington, Vice President of Patient Access at RWJBarnabas Health to explore how artificial intelligence is reshaping the work of access centers, shifting them from reactive call hubs to predictive, omni-channel orchestrators of the patient journey.They discuss why AI will likely handle most routine transactions while elevating human schedulers into empathetic care navigators, what it means to design access around the patient rather than the process, and how traditional metrics like abandonment rate and average speed of answer fall short of capturing true accessibility.In this episode, we cover AI's impact on scheduler roles, the rise of omnichannel digital front doors, new outcome- and experience-based access metrics, and why investing equally in people and platforms is essential to delivering frictionless, timely, connected care.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Clean, connected data is becoming the foundation for real progress in patient access, affordability, and care delivery. In this episode, Lynne Nowak, Chief Data and Analytics Officer at Surescripts, shares how her team is using data, automation, and emerging technologies to remove friction across the healthcare system. She explains how greater interoperability improves information flow among providers, payers, pharmacies, and patients, especially benefiting underserved populations. Lynne details how her organization evaluates AI by focusing on its real-world impact, utilizing it for high-value tasks such as reviewing complex medical records for prior authorizations and digitizing benefit verification. She also highlights new insights such as “first-fill abandonment” and previews upcoming work in adherence analytics, price transparency, and direct-to-patient capabilities. Tune in and discover how smarter data, automation, and real-time insights are transforming access, adherence, and the patient experience across the care continuum. Resources Connect with and follow Lynne Nowak on LinkedIn. Follow Superscripts on LinkedIn and visit their website!

Raymond Nistor-Gallo, Kurt Zatloukal, Karin Schwenoha. Regulatory Fragmentation in Europe and Its Risks for Patient Access and Safety: Subcontracting Work Flow Steps of In-House Diagnostic Procedures. Clinical Chemistry, Volume 71, Issue 12, December 2025, Pages 1202–1211. https://doi.org/10.1093/clinchem/hvaf123

In this episode of American Potential, host David From talks with Ohio Representative Jennifer Gross, a retired Air Force combat lieutenant colonel and longtime nurse practitioner, about her push to modernize Ohio's outdated healthcare rules. Rep. Gross explains how Ohio's Standard Care Arrangement requirement blocks highly trained nurse practitioners from providing care they're fully certified to deliver—especially harming patients in rural and underserved communities. She walks through why removing this mandate would: Expand access to doctors and nurse practitioners across Ohio Reduce wait times and improve patient choice Lower costs for patients and Medicaid Follow the lead of 27 states and 3 territories that have already done it She also shares how Ohio suspended the rule during COVID with no increase in patient harm, proving the system works without the red tape. Rep. Gross urges Ohioans to contact their legislators and support HB 508, the Better Access to Healthcare Act. A powerful conversation about healthcare freedom, patient choice, and letting professionals practice to the full extent of their training.

In this episode, Dr. Joseph Cacchione, Chief Executive Officer of Jefferson Health, and Alex Pinto, Principal at ECG Management Consultants, discuss how health systems can enhance patient access through standardized scheduling, technology integration, and strong physician engagement while navigating cultural and generational shifts in healthcare delivery.

Remission is no longer an abstract idea for people living with AiArthritis diseases. Thanks to earlier diagnosis, better treatment options, and growing global awareness, more patients are reaching remission and staying there. In this episode of AiArthritis Voices 360, Health Education Manager Leila P. L. Valete sits down with Neil Betteridge of the Global Remission Coalition to explore what remission truly means and why it is becoming a realistic goal for many. Together they unpack how remission differs from basic disease control and why that distinction is so important for daily life. They also talk through the emotional and practical impact of reaching remission, the role of early action, and the barriers that still prevent many patients from accessing timely care. The conversation highlights what sustainable remission looks like in the real world and how better education, support, and policy attention can help more people get there. Whether you are newly diagnosed or years into your patient journey, this episode offers a grounded and hopeful look at the road to remission and the steps that can make a life-changing difference.   Episode Highlights: What remission really means and how it differs from basic disease control Why remission improves quality of life, mental health, and daily function Key factors that help patients reach remission including early diagnosis and timely treatment Common barriers patients face like limited access to specialists, treatment delays, and lack of information What it takes to sustain remission through monitoring, adherence, and patient support   Links & Resources Global Remissions resources: www.globalremission.org AiArthritis remission information: https://www.aiarthritis.org/remission Have questions about this episode or topics you want to hear us bring to the table? Email us at podcast@aiarthritis.org  Donate to Support the Show: www.aiarthritis.org/donate   Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE   Connect with our Co Hosts: Leila is the Health Education Manager at the International Foundation for AiArthritis. She is a person living with Lupus and Sjögren's disease. She is passionate about inclusion and diversity in health education and meeting individuals where they are at in order to learn in a way that resonates with them.  Connect with Leila: Tiktok: @Lupuslifestyle.lei   Neil Betteridge developed juvenile arthritis at age three, an experience that shaped his lifelong commitment to advocating for people with chronic diseases. He has led major patient organizations in the UK and globally, including serving as CEO of Arthritis Care and now as Senior Director of the Global Alliance for Patient Access, where he also chairs the Global Remission Coalition. With decades of experience in public affairs and patient engagement, Neil has advised health ministers, worked with the Royal College of Physicians, and held key leadership roles in international networks such as the Global Alliance for Musculoskeletal Health and EULAR. His work continues to advance policy, access, and better outcomes for people living with chronic inflammatory conditions. Connect with Neil: Website: www.globalremission.org X/Twitter: https://x.com/Neil_Betteridge

About Lynne Nowak:Lynne Nowak, MD, is a seasoned physician executive and Chief Data and Analytics Officer with deep expertise at the intersection of clinical care, data, and technology. With 15 years of frontline experience as a board-certified internist and a decade leading large-scale data, interoperability, and clinical strategy initiatives, she has built a career transforming how information improves healthcare quality, access, and cost. She has overseen major enterprise investments, driven compliance with national interoperability standards, led advanced analytics and product development teams, and guided provider-focused digital solutions across complex organizations. Known for her high-energy, collaborative leadership style, she is committed to fixing a fragmented healthcare system while empowering patients, providers, and payers through smarter, connected data.Things You'll Learn:Interoperability between providers, payers, pharmacies, and patients is becoming a powerful driver of access and outcomes. When information flows cleanly, underserved communities benefit the most.AI is only valuable when applied to problems that require deeper analysis, not simple workflows. The real gains come from using AI to handle complex record reviews while leaving simpler tasks to traditional automation.First-fill abandonment affects 20–30% of prescriptions, and most systems fail to notice because no claim is generated. Having visibility into these “silent failures” allows clinicians and plans to intervene earlier.Electronic benefit verification replaces days of manual phone calls with instant eligibility checks for patient assistance programs. This significantly reduces friction for patients attempting to initiate therapy.Automating prior authorizations can cut decision times from days to under 30 seconds. That speed directly affects access, adherence, and overall patient health.Resources:Connect with and follow Lynne Nowak on LinkedIn.Follow Superscripts on LinkedIn and visit their website.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Trust is the foundation of data-driven healthcare transformation. In this episode, Ryan Weber, Solutions Consultant at TransUnion, discusses how data innovation is being leveraged to enhance patient access, minimize friction, and ensure equitable care for underserved populations. He explains how TransUnion's non-credit data, including contact, property, and behavioral information, helps healthcare organizations clean, verify, and enrich patient information to enhance outreach and engagement. Ryan shares how AI and automation streamline onboarding, reduce manual entry, and strengthen care continuity. He also highlights the company's focus on inclusive data strategies, regulatory compliance, and ethical data use to maintain trust while improving both financial outcomes and patient satisfaction. Tune in and learn how data intelligence and trust are shaping the next generation of patient-centered healthcare experiences! Resources Connect with and follow Ryan Weber on LinkedIn. Follow TransUnion on LinkedIn and visit their website! Email Ryan directly here.

In this episode, Vishwanath Singh breaks down how Infinx is modernizing quality assurance across both RCM and Patient Access through structured governance, risk-based sampling, and emerging AI copilots that strengthen accuracy and reduce variability. He explains how documentation, SOP creation, and auditing are being transformed into real-time, intelligence-driven processes that protect revenue and accelerate performance.

Send us a textAmy Grace, 50, is an accomplished professional and devoted mother, known for her resilience, integrity, and empathetic nature. She earned her master's degree from Gwynedd Mercy University in 2022 and currently serves as an Assistant Vice President of Patient Access, where she applies her leadership skills to ensure patients receive the care and support they need. A single mother of two sons, she has balanced a demanding career with a deep commitment to her family. Her oldest son, Mark, will turn 30 in December, and her youngest, Grady, is 12.In August 2023, Amy's family faced a profound challenge when her son Mark, then serving as a police officer, was charged following a police-involved shooting. After a lengthy legal process, he was found guilty of voluntary manslaughter. Despite the emotional toll of this experience, Amy and her family have remained steadfast in their values and she is raising her children to be honest, compassionate, and willing to help others in need. She draws strength from her family, which includes her three sisters, and honors the memory of her late parents by living a life rooted in love and empathy.Find The Suffering PodcastThe Suffering Podcast InstagramKevin Donaldson InstagramTom Flynn InstagramApple PodcastSpotifyYouTubeThe Suffering Podcast FamilySherri AllsupSupport the showThe Suffering Podcast Instagram Kevin Donaldson Instagram TikTok YouTube

Congressman Craig Murphy, a practicing physician and member of Congress from North Carolina, shares insights on current legislation and the state of healthcare in America. Congressman Murphy discusses the FBI's investigation into political conspiracies, the challenges facing Medicaid, and the importance of reforming the healthcare system to better serve those in need. He also addresses misinformation surrounding healthcare policies and the need for transparency and accountability in government. Next, former Deputy National Security Adviser Victoria Coates joins to discuss the recent NATO meeting with President Trump, the implications of sending Patriot missiles to Ukraine, and the potential for tougher sanctions on Russia. Victoria shares insights on how these developments could reshape international relations, particularly concerning China and the Middle East. Finally, former Trump lawyer and legal expert John Eastman delves into the decision by the FBI to open a grand conspiracy investigation focusing on alleged misconduct by Democrats over the past decade.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.